Table 2.
Tobacco Control Activities by Size of Health Plan, 2003 Addressing Tobacco in Managed Care Survey (N = 160)
| Activity | ≤250,000 Plan Members (N = 63), % Yes | >250,000 Plan Members (N = 97), % Yes | P Valuea |
| Plan has a written clinical guideline for smoking cessation | 25.4 | 61.5 | <.001 |
| Plan provides full coverage for | |||
| NRT over-the-counter gum | 5.1 | 9.3 | .34 |
| NRT over-the-counter patches | 8.5 | 10.3 | .71 |
| NRT inhalers | 20.3 | 18.6 | .78 |
| NRT nasal spray | 20.3 | 18.6 | .78 |
| Bupropion (as Zyban) | 37.3 | 24.7 | .10 |
| Bupropion (as Wellbutrin) | 83.1 | 83.5 | .94 |
| Plan provides full coverage for | |||
| Telephone counseling | 74.6 | 22.7 | <.001 |
| Face-to-face counseling | 69.5 | 15.5 | <.001 |
| Group counseling or classes | 28.8 | 16.5 | .07 |
| Individual counseling of pregnant women | 32.2 | 51.5 | .02 |
| Self-help materials | 32.2 | 53.6 | .01 |
| Plan has annual or lifetime limits on coverage for smoking cessation interventions | 25.8 | 15.5 | <.001 |
| Plan allows patients to self-refer to smoking cessation services | 50.9 | 47.0 | .67 |
| Plan is able to identify individual members who smoke | 88.4 | 92.8 | .56 |
| Plan has a strategy to address smoking cessation | |||
| During adolescence | 22.0 | 38.1 | .04 |
| During pregnancy | 40.7 | 85.6 | <.001 |
| During postpartum visits (relapse prevention) | 11.9 | 68.0 | <.001 |
| During pediatric visits (second hand smoke) | 13.6 | 39.2 | .001 |
| After myocardial infarction | 25.4 | 75.3 | <.001 |
| During treatment for other chronic illness | 37.3 | 81.4 | <.001 |
| During hospitalizations | 15.3 | 9.3 | .26 |
| Plan funds a tobacco control program staff position | 22.4 | 12.4 | .14 |
NRT indicates nicotine replacement therapy.
Proportions were compared using the chi-square test; results were considered statistically significant at P ≤.05.